KEYNOTE PANEL: The impact of geopolitics and geoeconomics on temperature controlled pharma supply chains

  • Assessing current geopolitical situations and their effect and potential effect on global cold chain logistics
  • Crisis management: developing strategies to cope with sudden unexpected logistical constraints
  • Navigating trade restrictions, sanctions and export controls impacting clinical and commercial pharma
  • Adapting route planning, carrier selection and packaging strategies in response to volatility
  • Strengthening supply chain resilience through diversification and proactive scenario planning

MODERATOR

Chris Wallace, Head of Distribution EMEA, Argenx

Fireside Chat: Hybrid sourcing solution: slashing costs and wastage

The high cost and significant wastage of rescue medication or comparators represent one of the most persistent financial drains in clinical trials. Traditional sourcing models often force an impossible choice between supply continuity and cost control. Learn from this practical case study, moving beyond theory to showcase a hybrid sourcing strategy that directly tackles this challenge

  • Implementing a hybrid model: Discovering how to blend different sourcing methods to minimize waste and cost for expensive rescue medications
  • Balancing cost vs. risk: Analyzing strategies that combine transparent pricing and supply chain visibility with robust contingency plans for shortages
  • Mastering global partner oversight: Discussing best practices for managing sourcing partners to maintain iron-clad compliance and protocol alignment across diverse regulatory regions
  • Building a resilient supply chain: Learning from a real-world case study how to design a sourcing plan that scales with your trial’s size and location, ensuring quality and consistency from start to finish

Moderator: Sonnika Lamont, Senior Analyst, GlobalData

Panel Discussion: Forging strong relationships and communication strategies as a clinical supply professional to enhance trial resilience and success

  • Breaking down silos to include clinical supply in other departmental discussions earlier
  • Bridging the gap between clinical supply, CMC, quality, clinical operations and other stakeholders
  • Utilizing robust relationships to be better prepared when running into problems conducting trials
  • Increasing the resilience of your trial through succinct collaboration

Sanofi´s IRT transformation journey through strategic collaboration

  • Sanofi’s IRT transformation journey, highlighting key challenges in clinical supply and technology delivery and how IRT functions as a core system to enable a scalable and resilient supply strategy.
  • Practical examples of how Sanofi leverages tailored IRT functionalities, advanced features, and specific integrations to optimize drug supply, enhance visibility, and drive operational efficiency.
  • How joint planning and strong partnership resulted in continued innovation and measurable improvements supporting Sanofi’s portfolio growth.

A demonstration of Digital Display Labels in Clinical Trials Operations & Supply Chain.

  • Exploring the capability of Digital Display Labels (DDLs) and the benefits for Clinical Trial Supplies
  • A demonstration of the functionality of DDLs; just in time labelling, lot & expiry update, multiple page count.
  • Understanding the operational ability to securely & remotely update content & language.
  • Integrating across IMP profiles, vials, bottles, blisters.